ElevateBio
ElevateBio is a technology-driven company built to power transformative genetic medicines today and for many decades to come.
Cambridge, United States · Founded 2017 · $551.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 201–500
- Founded
- 2017
- Business Model
- Other
- Website
- elevatebio.com
- Total Funding
- $551.0M
- Last Round
- $401.0M Venture RoundMay 2023
- Rounds
- 2
About
Founded in 2017, ElevateBio breaks down barriers in cell and gene therapy with BaseCamp cGMP manufacturing and HighPass R&D. It supports genetic medicines from concept to commercialization with world-class expertise.
Summary
ElevateBio is a Biotech company based in Cambridge, United States, founded in 2017. It has raised $551.0M in total across 2 rounds, most recently a $401.0M Venture Round round in May 2023.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
May 2023
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company